Examining the management of diabetes in special populations

September 29, 2017

Diabetes affects roughly 30 million Americans, and is one of the leading causes of disability and mortality. As a result, organizations such as the American Diabetes Association (ADA), Endocrine Society and American Association of Clinical Endocrinologists (AACE) have made efforts to move away from the one size fits all management of diabetes. Instead, diabetes management is now customized based on patient variables such as age, life expectancy, co-morbid conditions, finances, and patient goals.

As a result this special issue of Current Diabetes Review guest edited by Dr. Alyson Myers explores the management of diabetes in medically complex patients. The ADA has recently released a statement in November 2016 on the need to assess for psychosocial issues that impair diabetes management. Two articles of this special issue address mental illness. In the article Diabetes and Schizophrenia, Dr. Jeffrey Rado explores the association between diabetes and schizophrenia. Antipsychotic medications, as well as sedentary lifestyle make this population vulnerable to developing diabetes. Drs. Madhuker Trivedi and Alyson Myers discuss the management of the self-harming or suicidal patient with diabetes. Insulin is considered a high risk medication, thus it can be manipulated to cause severe hyper or hypoglycemia which can both potentially lead to death.

In addition to the integration of psychosocial assessment into diabetes management, weight management is also a part of diabetes care. Drs. Maria Pena and Trisha Newaz review post-bariatric surgery care for those with diabetes. Many of these patients require medication adjustments due to hormonal changes which decrease insulin resistance. Those with shorter duration of diabetes or on oral agents have a greater chance of reversal of diabetes with bariatric surgery.

Another group of persons with diabetes who require specialized care are older adults. Dr. Nana Yaw Adu-Sarkodie, gerontologist describes how aging can affect glucose metabolism. Also he explores the need medication adjustments and vulnerability of the elderly to side effects of diabetic medications. Elderly patients are at increased risk of hospitalizations, so the transitions of care from the inpatient to outpatient setting are examined by Nurse Practitioner Patricia Garnica.

Lastly we still have not closed the gap on the poorer outcomes for disparity populations. Non-white Hispanics have lower rates of complications when compared to ethnic minorities. Dr. Maya Fayfman explores the biological and psychosocial variables leading to this.

This special edition is aimed for health care providers who manage persons with diabetes in both the inpatient and ambulatory care settings.
-end-
Read the articles in this special issue here: http://benthamscience.com/journals/current-diabetes-reviews/volume/13/issue/3/

Bentham Science Publishers

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.